Rehovot, Israel and Paris, France
June 13, 2006
Evogene Ltd.
and Biogemma announced
today their participation in the TAGIP European FP6 research
consortium. The TAGIP consortium is focused on enabling the
targeted integration of genes in plants.
The consortium, led by Professor Avi Levy of the Weizmann
Institute of Science, includes, in addition to the two
commercial partners, six academic institutions. The academic
partners include: Prof. Karel Angelis of the Institute of
Experimental Botany of the Czech Academy of Sciences (Czech
Republic), Prof.
Jerzy
Paszkowski of
the
University of Geneva (Switzerland), Prof. Holger Puchta of
Karlsruhe University (Germany) and
Prof. Charles White of the Centre National de la
Recherche Scientifique (France).
Dr Hagai Karchi, Evogene’s VP of R&D stated: “We
are pleased to participate in this consortium with such an elite
group of partners. The TAGIP partnership will provide Evogene
with additional state-of-the art tools for precise engineering
of plant genomes. We anticipate that all our projects can
benefit from those tools, in particular, we will evaluate the
use of the technology for our Plant Manufactured Protein
project.”
Dr Pascual Perez, Biogemma’s Research
Coordinator: “The technology is designed to allow the
introduction of genes in plants in a targeted area of the
genome, which can significantly improve the speed at which
modified plants can be developed, minimizing the transformation
position effect, and thereby simplifying the regulatory process.
This program is therefore of particular interest for the whole
seed industry. “
Evogene is a biotechnology company focused on developing
high-value commercial products based on plant genomics. The
company is merging state-of-the-art predictive computational
biology and molecular biology with the most advanced breeding
technologies. Evogene’s current product development portfolio
is focused on: improving abiotic stress tolerance and yield in
key crops such as corn, soya, cotton, tomato and canola;
enhancing fiber development in cotton; improving nitrogen use
efficiency for key crops and plant manufacturing of therapeutic
proteins. Evogene was founded in 2002 by
Drs. Hagai
Karchi and Rafi Meissner as a plant
biotechnology spin-off of Compugen Ltd. (Nasdaq: CGEN) and has a
broad license to utilize certain Compugen technology in the
agbio field.
Biogemma is a leading biotech company in Europe
involved in Genomics applied to Field crops. The company is
developing R&D programs with its partners, mainly in corn and
wheat focused on biotic and abiotic stresses and specialty grain
compounds. |